The Top 10 Public Policy Issues for 2024 Bloomberg Government

The debate has offered a test run of the highly anticipated 2025 tax debate, when the Trump-era tax cuts are set to expire. Republicans in the House and Democrats in the Senate will need to forge compromises to get legislation signed into law. Relatively few laws were signed in 2023, reflecting divided control of government and narrow majorities in both the House and Senate.

Policies That Work Series

Seventy percent of registered voters in this election cycle identified the economy as one of their top public policy concerns. This framework presents a practical way of connecting a clear objective with the specific context and the type of research to carry out. In each section, there is a direct link between the type of problem, what is feasible to achieve in terms of policy influence, and how research can help. Always ahead of the curve, HCG is spearheading the charge to turn scientific potential into real-world impact. In 2025, the second round of negotiations will get rolling, with CMS set to publish the list of the next 15 drugs selected for 2027 by this February. Negotiations will continue throughout the year, with the next negotiated maximum fair prices to be set by November.

Public Policy Definition

With prevention, action is usually long-term, more complex to control, less visible, harder to measure and more likely to involve controversial choices, making it more difficult to make progress without building coalitions. Some actions to reduce social risks may be politically opposed by those who regard it as ‘social engineering’. Public (and private) administrative data offer the prospect of large amounts of information at relatively low cost. These data are created when people interact with public services and can be linked with rich survey data. Tanden, born to Indian immigrants, was raised in Massachusetts, and a Massachusetts housing policy played a pivotal role in her upbringing. It involves a systematic process of policy formulation, implementation, and evaluation, drawing upon research, stakeholder consultations, and political considerations.

The Trump administration’s industry-friendly approach is already partially playing out, with the president-elect recently meeting with the CEOs of Eli Lilly, Pfizer and industry lobbying group PhRMA at Mar-a-Lago. Since their meeting, Trump has spoken about targeting pharmacy benefit managers (PBMs) rather than calling out Big Pharma directly. The U.S. is one of only two countries in the world that allow pharma companies to advertise branded drugs directly to consumers.

A bipartisan group of senators is looking to restrict credit card “swipe fees,” also known as interchange fees, that merchants pay when customers buy something blog written by Dr. Stephen Bryen with a credit card. Merchants and retailers are supportive of the bipartisan bill (S. 1838), while credit card companies, banks, and other financial industry players are getting involved to fight it. The legislation has already been the focus of a flurry of lobbying activity, including a multimillion-dollar ad campaign. After capping the price of insulin for Medicaid patients, lawmakers are eyeing a similar curb for those with private health insurance. The Senate is considering two main proposals that would cap the out-of-pocket cost of insulin at $35 per month for patients with private insurance.